Zhuqian Wang

Hong Kong Baptist University — Hong Kong

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index627citations39works8.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Degradation and Inhibitors(7), Catalytic Processes in Materials Science(6), Zeolite Catalysis and Synthesis(6), Mesoporous Materials and Catalysis(5), Ubiquitin and proteasome pathways(4)

Publications39 total

snoRNA <i>Snord3</i> promotes rheumatoid arthritis by epigenetic regulation of ESM1 in fibroblast-like synoviocytes in mice
Science Translational Medicine·2025· 1 cited
PSMA-targeted CAR-macrophages drive glycolytic reprogramming for enhanced prostate cancer immunotherapy
Journal of Hematology & Oncology·2025· 5 citedOpen Access
An aptamer specifically targeting mCRP ameliorates experimental arthritis
Journal of Orthopaedic Translation·2025Open Access
Progress of dispersion polymerization in recent 15 years
Journal of Polymer Research·2025· 2 cited
Auricularia heimuer Ameliorates Oxidative Stress and Inflammation to Inhibit Atherosclerosis Development in ApoE−/− Mice
Nutrients·2025· 1 citedOpen Access
Correction to “Discovery of a Natural Ent-Kaurene Diterpenoid Oridonin as an E3 Ligase Recruiter for PROTACs”
Journal of the American Chemical Society·2025Open Access
Anoikis Resistance and Tumor Metastasis
2025
Leveraging artificial intelligence and machine learning for unraveling pathogenesis and advancing precision medicine in autoimmune diseases
The Innovation Medicine·2025· 3 citedOpen Access
Unveiling the Therapeutic Potential: Targeting Fibroblast-like Synoviocytes in Rheumatoid Arthritis
Expert Reviews in Molecular Medicine·2025· 9 citedOpen Access
Discovery of a Natural Ent-Kaurene Diterpenoid Oridonin as an E3 Ligase Recruiter for PROTACs
Journal of the American Chemical Society·2024· 17 cited
Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma
Theranostics·2024· 16 citedOpen Access
Development of hybrid aptamers-engineered PROTACs for degrading VEGF165 in both tumor- and vascular endothelial cells
European Journal of Medicinal Chemistry·2024· 8 cited
Design of Murine Double Minute 2 Proteolysis Targeting Chimera Degraders with a Built-In Tumor-Targeting Ability
Journal of Medicinal Chemistry·2024· 7 cited
Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity
Nature Communications·2024· 13 citedOpen Access
Generation of cytotoxic aptamers specifically targeting fibroblast-like synoviocytes by CSCT-SELEX for treatment of rheumatoid arthritis
Annals of the Rheumatic Diseases·2024· 23 cited
Gut microbial metabolite targets HDAC3-FOXK1-interferon axis in fibroblast-like synoviocytes to ameliorate rheumatoid arthritis
Bone Research·2024· 28 citedOpen Access
Repurposing AS1411 for constructing ANM-PROTACs
Cell chemical biology·2024· 23 cited
CRISPRa engineered Elite macrophages enable adoptive cell therapy for rheumatoid arthritis
The Innovation Medicine·2024· 9 citedOpen Access
Design of Mdm2 Protac Degraders with a Built-In Tumor-Targeting Ability
SSRN Electronic Journal·2024Open Access
Anoikis Resistance and Tumor Metastasis
2023· 1 cited
page 1 of 2Next →

Frequent Co-authors

Chao Liang(16), Duoli Xie(15), Aiping Lü(13), Chunhao Cao(10), Qiubin Kan(9), Hongzhen Chen(9), Jingqi Guan(8), Xuekun Fu(8), Yiying Liang(8), Fang Qiu(7), Chen Xu(6), Di Wang(6), Siran Yue(6), Jie Huang(5), Shujie Wu(4), Yuanyuan Ma(4), Ke Song(4), Haiyan Xu(4), Xinxin Chen(4), Fang Qiu(4)